In conclusion, our current data demonstrate reduced body weight, hepatic steatosis, and plasma insulin levels in CCL3−/−→LDLR−/− compared to C57BL/6→LDLR−/− mice. This evidence concerns the gene CCL3 and Hepatic steatosis.